A Revised CAR T for Lymphoma Has Fewer Side Effects
Kerry Grens | Apr 23, 2019
An early-stage clinical study finds that none of the 25 patients treated developed neurotoxicity or cytokine release syndrome, common hazards of the cancer immunotherapy.
CRISPRed B Cells Produce Antibodies Against Hard-to-Treat Viruses
CRISPRed B Cells Produce Antibodies Against Hard-to-Treat Viruses
In line with previous research, a new study in mice demonstrates that B cells can be engineered to ward off infections, this time against respiratory syncytial virus (RSV).
In line with previous research, a new study in mice demonstrates that B cells can be engineered to ward off infections, this time against respiratory syncytial virus (RSV).
Gene Therapy Effective for Severe Combined Immunodeficiency
Shawna Williams | Apr 17, 2019
Researchers report they’ve found a way to restore immune function in infants with one form of “bubble boy disease.”
Culprit for Antibody Blockade Identified
Amanda B. Keener | Oct 21, 2016
Type I interferon organizes several immune mechanisms to suppress B cell responses to a chronic viral infection.
B Cell Bosses
Kate Yandell | Feb 1, 2015
Gut bacteria in mice spur regulatory B cells to differentiate and release an anti-inflammatory cytokine.
Repurposed Retroviruses
Ruth Williams | Dec 18, 2014
B cells have commandeered ancient viral sequences in the genome to transmit antigen signals.
Immune System Kills Cancer
Kate Yandell | Mar 27, 2013
T-cells engineered to attack B-cells sent adults’ acute leukemia into remission.
Thymus Finder
Richard P. Grant | Jul 1, 2011
Editor’s Choice in Immunology